Competent Cells Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Competent Cells Market to 2027 - Global Analysis and Forecasts By Type (Chemically Competent Cells and Electrocompetent Cells) Application (Cloning, Protein Expression and Other Applications) End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies and Contract Research Organizations)

Report Code: TIPBT00002547 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Cells that are more likely to incorporate foreign DNA if their cell walls are altered so that DNA can pass through more easily. Such cells are said to be competent. Cells are made competent by a process that uses calcium chloride and heat shock. Cells that are undergoing very rapid growth are made competent more easily than cells in other stages of growth.

The market of competent cells is anticipated to grow with a significant rate in the coming years, owing to factors such as, the advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins. Various technological developments in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for the players operating in the competent cells market.

The "Global Competent Cells Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global competent cells market with detailed market segmentation type, application and end user. The global competent cells market is expected to witness high growth during the forecast period. The competent cells market report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global competent cells market is segmented on the basis of type, application and end user. The type segment includes, chemically competent cells and electrocompetent cells. Based on application, the market is segmented as, cloning, protein expression and other applications. Based on end user, the market is segmented as, academic research institutes, pharmaceutical & biotechnology companies and contract research organizations.

The competent cells market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global competent cells market based on type, application and end user. It also provides market size and forecast till 2027 for overall competent cells market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the competent cells market in the coming years, owing to factors such as, increasing intensity of research due to technological advancement and increasing commercial needs for genomic and protein expressed products. Asia Pacific is also expected to witness tremendous growth due to presence of emerging economies like China and India.

The competent cells market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key competent cells companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Merck KGaA, Promega Corporation, Takara Bio, Inc., New England Biolabs, Bio-Rad Laboratories, Inc., Agilent Technologies, Illumina, Inc., Qiagen, Genscript, Origene Technologies, Inc.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. COMPETENT CELLS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Competent cells Market - By Type
3.2.2. Competent cells Market - By Application
3.2.3. Competent cells Market - By End User
3.2.4. Competent cells Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. COMPETENT CELLS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. COMPETENT CELLS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL COMPETENT CELLS MARKET OVERVIEW
5.2. GLOBAL COMPETENT CELLS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. GLOBAL COMPETENT CELLS MARKET VOLUME FORECASTS AND ANALYSIS ('000 UNITS)
5.4. MARKET POSITIONING/MARKET SHARE
5.5. PERFORMANCE OF KEY PLAYERS
5.6. EXPERT OPINIONS
6. COMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2027 - BY TYPE
6.1. OVERVIEW
6.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. CHEMICALLY COMPETENT CELLS MARKET
6.3.1. Overview
6.3.2. Chemically Competent Cells Market Revenue Forecasts and Analysis (US$ Mn)
6.4. ELECTROCOMPETENT CELLS MARKET
6.4.1. Overview
6.4.2. Electrocompetent Cells Market Revenue Forecasts and Analysis (US$ Mn)
7. COMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2027 - BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. CLONING MARKET
7.3.1. Overview
7.3.2. Cloning Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. SUBCLONING & ROUTINE CLONING MARKET
7.3.3.1. Overview
7.3.3.2. Subcloning & Routine Cloning Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4. PHAGE DISPLAY LIBRARY CONSTRUCTION MARKET
7.3.4.1. Overview
7.3.4.2. Phage Display Library Construction Market Revenue Forecasts and Analysis (US$ Mn)
7.3.5. TOXIC/UNSTABLE DNA CLONING MARKET
7.3.5.1. Overview
7.3.5.2. Toxic/Unstable DNA Cloning Market Revenue Forecasts and Analysis (US$ Mn)
7.3.6. HIGH-THROUGHPUT CLONING MARKET
7.3.6.1. Overview
7.3.6.2. High-Throughput Cloning Market Revenue Forecasts and Analysis (US$ Mn)
7.4. PROTEIN EXPRESSION MARKET
7.4.1. Overview
7.4.2. Protein Expression cells Market Revenue Forecasts and Analysis (US$ Mn)
7.5. OTHER APPLICATIONS MARKET
7.5.1. Overview
7.5.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
7.5.3. MUTAGENESIS MARKET
7.5.3.1. Overview
7.5.3.2. Mutagenesis Market Revenue Forecasts and Analysis (US$ Mn)
7.5.4. LARGE PLASMID TRANSFORMATION MARKET
7.5.4.1. Overview
7.5.4.2. Large Plasmid Transformation Market Revenue Forecasts and Analysis (US$ Mn)
7.5.5. SINGLE-STRANDED DNA PRODUCTION MARKET
7.5.5.1. Overview
7.5.5.2. Single-Stranded DNA Production Market Revenue Forecasts and Analysis (US$ Mn)
7.5.6. LENTIVIRAL VECTOR PRODUCTION MARKET
7.5.6.1. Overview
7.5.6.2. Lentiviral Vector Production Market Revenue Forecasts and Analysis (US$ Mn)

8. COMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2027 -BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. ACADEMIC RESEARCH INSTITUTES MARKET
8.3.1. Overview
8.3.2. Academic Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
8.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
8.4.1. Overview
8.4.2. Pharmaceutical & Biotechnology Companies Market Revenue Forecasts and Analysis (US$ Mn)
8.5. CONTRACT RESEARCH ORGANIZATIONS MARKET
8.5.1. Overview
8.5.2. Contract Research Organizations Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA COMPETENT CELLS MARKET OVERVIEW
9.2. NORTH AMERICA COMPETENT CELLS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.4. NORTH AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.5. NORTH AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
9.7. US MARKET OVERVIEW
9.7.1. US Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.2. US Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7.3. US Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.2. Canada Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8.3. Canada Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.9.2. Mexico Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.9.3. Mexico Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE COMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE COMPETENT CELLS MARKET OVERVIEW
10.2. EUROPE COMPETENT CELLS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.4. EUROPE COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.5. EUROPE COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
10.7. FRANCE MARKET OVERVIEW
10.7.1. France Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.2. France Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.3. France Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.2. Germany Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.3. Germany Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. UK MARKET OVERVIEW
10.9.1. UK Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.9.2. UK Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.9.3. UK Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC COMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC COMPETENT CELLS MARKET OVERVIEW
11.2. ASIA PACIFIC COMPETENT CELLS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.4. ASIA PACIFIC COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.5. ASIA PACIFIC COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
11.7. CHINA MARKET OVERVIEW
11.7.1. China Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.7.2. China Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.3. China Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.8.2. India Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.3. India Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. JAPAN MARKET OVERVIEW
11.9.1. Japan Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.9.2. Japan Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.9.3. Japan Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) COMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) COMPETENT CELLS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) COMPETENT CELLS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA) COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.7.2. South Africa Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.7.3. South Africa Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.8.2. Saudi Arabia Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.8.3. Saudi Arabia Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.9.2. UAE Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.9.3. UAE Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA COMPETENT CELLS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA COMPETENT CELLS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA COMPETENT CELLS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY (US$ MN)
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Competent cells Market Revenue Forecasts and Analysis - By Type (US$ Mn)
13.7.2. Brazil Competent cells Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.7.3. Brazil Competent cells Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. COMPETENT CELLS MARKET, INDUSTRY LANDSCAPE
14.1. GROWTH STRATEGIES
15. COMPETENT CELLS MARKET, KEY COMPANY PROFILES
15.1. PROMEGA CORPORATION
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Type Portfolio
15.1.5. Type Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. TAKARA BIO, INC.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Type Portfolio
15.2.5. Type Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. NEW ENGLAND BIOLABS
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Type Portfolio
15.3.5. Type Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. MERCK KGAA
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Type Portfolio
15.4.5. Type Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. BIO-RAD LABORATORIES, INC.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Type Portfolio
15.5.5. Type Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. AGILENT TECHNOLOGIES
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Type Portfolio
15.6.5. Type Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. ILLUMINA, INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Type Portfolio
15.7.5. Type Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. QIAGEN
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Type Portfolio
15.8.5. Type Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. GENSCRIPT
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Type Portfolio
15.9.5. Type Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. ORIGENE TECHNOLOGIES, INC.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Type Portfolio
15.10.5. Type Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Merck KGaA
2. Promega Corporation
3. Takara Bio, Inc.
4. New England Biolabs
5. Bio-Rad Laboratories, Inc.
6. Agilent Technologies
7. Illumina, Inc.
8. Qiagen
9. Genscript
10. Origene Technologies, Inc.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book